Effects of urinary macromolecules on the crystallization of calcium oxalate
- PMID: 2100412
- DOI: 10.1007/BF00297369
Effects of urinary macromolecules on the crystallization of calcium oxalate
Abstract
The macromolecular fraction of urine with a molecular weight above 3,000 was isolated by dialysis. In the dialysed urine the rate of calcium oxalate (CaOx) crystallization was reduced both in the presence and absence of CaOx seed crystals. There was a clear relationship between crystallization and the relative concentration of the dialysed urine, with the highest crystallization propensity at the lowest concentration of macromolecules. Dilution of dialysed urine also affected crystal size distribution, with a predominance of small (2.8-4.5 microns) crystals in 100% dialysed urine and of large (5.6-14.0 microns) crystals in 5% dialysed urine. This is consistent with a macromolecular inhibition of both crystal growth and aggregation. Analysis of the crystal size distribution 120 min after supersaturation of whole urine to a level at which approximately 100 crystals in the size interval 3.5-5 microns were detected in a Coulter counter surprisingly disclosed a higher mean crystal volume in urine samples from normal subjects than from stone formers. This gives support to the assumptions that macromolecules might be of importance during the initial phase of CaOx crystallization and that urine from stone formers and normal subjects might be different in this respect.
Similar articles
-
Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.Kidney Int. 1999 Mar;55(3):1041-50. doi: 10.1046/j.1523-1755.1999.0550031041.x. Kidney Int. 1999. PMID: 10027942
-
Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.Acta Biomed. 2002;73(1-2):11-26. Acta Biomed. 2002. PMID: 12233273
-
Crystallisation properties in stone forming and normal subjects' urine diluted using a standardised procedure to match the composition of urine in the distal part of the distal tubule and the middle part of the collecting duct.Urol Res. 2001 Apr;29(2):75-82. doi: 10.1007/s002400100174. Urol Res. 2001. PMID: 11396732
-
Glycoprotein calcium oxalate crystal growth inhibitor in urine.Miner Electrolyte Metab. 1987;13(4):267-72. Miner Electrolyte Metab. 1987. PMID: 3306319 Review.
-
Inhibitors of stone formation.Semin Nephrol. 1996 Sep;16(5):474-86. Semin Nephrol. 1996. PMID: 8890402 Review.
Cited by
-
Effect of urinary macromolecules on aggregation of calcium oxalate in recurrent calcium stone formers and healthy.Urol Res. 1993;21(4):265-8. doi: 10.1007/BF00307708. Urol Res. 1993. PMID: 8212414
-
[Calcium oxalate stones and hyperoxaluria. What is certain? What is new?].Urologe A. 2005 Nov;44(11):1315-23. doi: 10.1007/s00120-005-0936-z. Urologe A. 2005. PMID: 16235094 Review. German.
-
Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers.Urol Res. 1997;25(5):365-72. doi: 10.1007/BF01294667. Urol Res. 1997. PMID: 9373919
-
Is citrate an inhibitor of calcium oxalate crystal growth in high concentrations of urine?Urol Res. 1996;24(2):67-71. doi: 10.1007/BF00431081. Urol Res. 1996. PMID: 8740974
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical